From April 1, 2024 to June 30, 2024, the company has repurchased 967,600 shares, representing 0.73% for CNY 56.37 million. With this, the company has completed the repurchase of 2,117,600 shares, representing 1.59% for CNY 118.8 million under the buyback announced on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.36 CNY | +3.50% |
|
+3.64% | -32.47% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.47% | 924M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.45% | 32.76B | |
+79.34% | 29.46B | |
-12.21% | 16.31B | |
+3.48% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on January 23, 2024.